These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8197078)

  • 1. [Toxic lung damage caused by mitomycin C].
    Lenci G; Müller-Quernheim J; Lorenz J; Schweden F; Ferlinz R
    Pneumologie; 1994 Mar; 48(3):197-201. PubMed ID: 8197078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lung toxicity of trimodality chemoradiotherapy with mitomycin C, vindesine, and cisplatin followed by surgery for locally advanced non-small cell lung cancer].
    Sawa T; Yoshida T; Ishiguro T; Ogawara M; Kawahara M; Yamamoto S; Yokota S; Maeda H; Asamoto H
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1745-9. PubMed ID: 14619509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lung sarcoidosis following instillation of mitomycin C in the urinary bladder].
    Cuervo Pinna MA; Cuervo Pinna C; Macías Castillo S; Bureo Dacal JC; Espada Alonso MJ; Pimentel Leo J
    An Med Interna; 2001 Dec; 18(12):641-3. PubMed ID: 11852501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary infiltrates with masto- and lymphocytosis in BALF associated with arechine.
    Jedynak U; Ciezarek M; Kopiński P
    Pol J Pathol; 1997; 48(1):63-7. PubMed ID: 9200963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
    Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
    Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of flow cytometry in evaluation of cellular changes in interstitial lung diseases].
    Kopiński P
    Folia Med Cracov; 1997; 38(3-4):69-115. PubMed ID: 10481384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rapidly progressing respiratory insufficiency of uncertain etiology].
    Bingisser RM; Gutmann M; Dalquen P
    Schweiz Med Wochenschr; 2000 Dec; 130(51-52):2001-8. PubMed ID: 11688068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchiolitis obliterans-organizing pneumonia: an Italian experience.
    Cazzato S; Zompatori M; Baruzzi G; Schiattone ML; Burzi M; Rossi A; Ratta L; Terzuolo G; Falcone F; Poletti V
    Respir Med; 2000 Jul; 94(7):702-8. PubMed ID: 10926343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contribution of bronchoalveolar lavage and transbronchial biopsy to diagnosis and prognosis of drug-induced pneumopathies].
    Rosner V; Chabot F; Moreau L; Grignon Y; Delorme N; Polu JM
    Rev Pneumol Clin; 1995; 51(5):269-74. PubMed ID: 8745751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug-induced lung changes in rheumatology].
    Costabel U
    Z Rheumatol; 1990; 49(5):284-90. PubMed ID: 2080685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug-induced pneumopathies (excluding cytostatic drugs)].
    Akoun G; Milleron B; Mayaud C
    Ann Med Interne (Paris); 1989; 140(7):593-6. PubMed ID: 2610452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchoalveolar lavage in idiopathic interstitial lung diseases.
    Nagai S; Handa T; Ito Y; Takeuchi M; Izumi T
    Semin Respir Crit Care Med; 2007 Oct; 28(5):496-503. PubMed ID: 17975777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dosage of anticancer agents during transcatheter arterial chemoembolization on T cell subsets in patients with hepatocellular carcinoma.
    Lu W; Li YH; He XF; Chen Y; Zeng QL; Qiu YR
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Jun; 22(6):524-6. PubMed ID: 12297475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of CD103 as a cellular marker for the diagnosis of pulmonary sarcoidosis.
    Heron M; Slieker WA; Zanen P; van Lochem EG; Hooijkaas H; van den Bosch JM; van Velzen-Blad H
    Clin Immunol; 2008 Mar; 126(3):338-44. PubMed ID: 18182176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alveolitis and pulmonary fibrosis in chronic diverticulitis and ulcerative colitis].
    Büntzel J; Liebetrau G
    Pneumologie; 1994 Jan; 48(1):16-9. PubMed ID: 7908743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental and clinical data of the pulmonary toxicity of mitomycin C].
    Gatzemeier U; Fasske E; Nowak U
    Pneumologie; 1990 Feb; 44 Suppl 1():201-3. PubMed ID: 2114625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [T-lymphocyte subpopulations in bronchoalveolar lavage in pulmonary sarcoidosis and other interstitial pulmonary diseases].
    Petrek M; Kolek V
    Cas Lek Cesk; 1993 Jun; 132(12):365-8. PubMed ID: 8343944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A characterization of amiodarone-induced pulmonary toxicity in F344 rats and identification of surfactant protein-D as a potential biomarker for the development of the toxicity.
    Taylor MD; Van Dyke K; Bowman LL; Miles PR; Hubbs AF; Mason RJ; Shannon K; Reasor MJ
    Toxicol Appl Pharmacol; 2000 Sep; 167(3):182-90. PubMed ID: 10986009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease: prospective study of a cohort of 562 patients].
    Jara-Palomares L; Martín-Juan J; Gómez-Izquierdo L; Cayuela-Domínguez A; Rodríguez-Becerra E; Rodríguez-Panadero F
    Arch Bronconeumol; 2009 Mar; 45(3):111-7. PubMed ID: 19286112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
    Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.